Concepedia

Rebecca A. Boyd

RA

Statistics

Publications

26

Citations

2.7K

H-Index

21

Active since

1987

Affiliations

Pfizer (United States)(Current)

Bristol-Myers Squibb (United States)

University of California, San Francisco

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Rebecca A. Boyd is an author at Pfizer (United States) specializing in pharmacology, pharmacokinetics, and clinical pharmacology.

Publications per year

1987–2018

26

Publications

26

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis

Xiaoli Wang, Giridhar Tirucherai, Thomas Marbury et al. · The Journal of Clinical Pharmacology · 2015 · 284 citations · Full text

, , +17

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor<scp>X</scp>a inhibitor, in healthy subjects

Charles Frost, Sunil Nepal, Jessie Wang et al. · British Journal of Clinical Pharmacology · 2013 · 282 citations · Full text

, , +17

Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects

Vijay Upreti, Jessie Wang, Yu Chen Barrett et al. · British Journal of Clinical Pharmacology · 2013 · 269 citations · Full text

, , +17

Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development

Peter A. Milligan, Marcy Brown, B Marchant et al. · Clinical Pharmacology & Therapeutics · 2013 · 236 citations

, , +10

Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers

Howard N. Bockbrader, Louis L. Radulovic, Edward L. Posvar et al. · The Journal of Clinical Pharmacology · 2010 · 186 citations

, , +14

1–5 of 26